Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-25
2010-11-16
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S157000, C546S167000
Reexamination Certificate
active
07834029
ABSTRACT:
A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
REFERENCES:
patent: 2004/0106604 (2004-06-01), Beight et al.
patent: 0 531 901 (1993-03-01), None
patent: WO 02 094833 (2002-11-01), None
patent: WO 2004/048383 (2004-06-01), None
Edlund, Molecular Biology of the Cell, vol. 14, pp. 529-544, Feb. 2003.
Butta, Cancer Research, vol. 52, pp. 4261-4264, Aug. 1992.
Anscher, et al. (1993) N. Engl. J. Med. 328: 1592-1598.
Arteaga, et al. (1993) J. Clin. Invest. 92:2569-2576.
Arteaga, et al. (1993) Cell Growth and Differ. 4:193-201.
Dickson, et al. (1987) Proc. Natl. Acad. Sci. USA 84:837-841.
Daly, et al. (1990) J. Cell Biochem. 43:199-211.
King, et al. (1989) J. Steroid Biochem. 34:133-138.
Welch, et al. (1990) Proc. Natl. Acad. Sci. USA 87:7678-7682.
Walker, et al. (1992) Eur. J. Cancer 28:641-644.
Beight Douglas Wade
Sawyer Jason Scott
Yingling Jonathan Michael
Eli Lilly and Company
Hostettler Danica
McGraw Elizabeth A.
Seaman D. Margaret
Tucker Tina M.
LandOfFree
Quinolinyl-pyrrolopyrazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolinyl-pyrrolopyrazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolinyl-pyrrolopyrazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4178670